Öztürk et al. [23] reported significantly lower ANXA3 levels in both schizophrenia and bipolar disorder patients compared with healthy controls, emphasizing that the most pronounced decreases were in schizophrenia patients. The gene discussed is ANXA3; the disease is bipolar disorder.